group,serum,virus,replicate,titer,titer_bound,titer_as,nt50,midpoint,top,bottom,slope
CellVaccineCohort,AUS24_s010_prevax,A/Philippines/10/2023,plate13-GGTCCACAAGCATCCT,40,upper,midpoint,40,40,0.7172,0,3.334
CellVaccineCohort,AUS24_s010_prevax,A/Philippines/10/2023,plate13-TAACCGGGGAATCATT,48.65,interpolated,midpoint,65.19,48.65,0.656,0,3.979
CellVaccineCohort,AUS24_s010_prevax,A/Philippines/10/2023,plate13-CCAAGCTAGGTCGACA,40,upper,midpoint,41.57,40,0.7258,0,2.151
CellVaccineCohort,AUS24_s010_prevax,A/Thies/1247/2023,plate13-AACGAAAAGAATAAGC,50.27,interpolated,midpoint,99.57,50.27,0.6458,0,1.803
CellVaccineCohort,AUS24_s010_prevax,A/Thies/1247/2023,plate13-ATTATGTCGTGACAGT,66.53,interpolated,midpoint,93.48,66.53,0.7555,0,1.974
CellVaccineCohort,AUS24_s010_prevax,A/Thies/1247/2023,plate13-CCCGACAAAGCCCTCG,87.6,interpolated,midpoint,94.03,87.6,0.7462,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Oregon/32/2023,plate13-GCCTTGCATTAGGAAC,40,upper,midpoint,54.82,40,0.6743,0,3.244
CellVaccineCohort,AUS24_s010_prevax,A/Oregon/32/2023,plate13-ATTGTGAAGAATTGCT,40.58,interpolated,midpoint,45.46,40.58,0.6606,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Oregon/32/2023,plate13-CGTATACAAACGCGAC,40,upper,midpoint,65.84,40,0.6402,0,1.856
CellVaccineCohort,AUS24_s010_prevax,A/Pennsylvania/51/2023,plate13-ACCAAAGCTGAATGGA,49.22,interpolated,midpoint,84.13,49.22,0.6331,0,2.469
CellVaccineCohort,AUS24_s010_prevax,A/Pennsylvania/51/2023,plate13-ACAGTCGCAGGGAATA,54.22,interpolated,midpoint,84.49,54.22,0.7183,0,1.868
CellVaccineCohort,AUS24_s010_prevax,A/Brazil/GIHSN-HCL023128467501/2023,plate13-ATTCGAAGACAGAGGG,40,upper,midpoint,50.22,40,0.6386,0,2.983
CellVaccineCohort,AUS24_s010_prevax,A/Brazil/GIHSN-HCL023128467501/2023,plate13-ACTAATCGCAACTAGA,40,upper,midpoint,62.77,40,0.6833,0,2.169
CellVaccineCohort,AUS24_s010_prevax,A/Brazil/GIHSN-HCL023128467501/2023,plate13-CCTTGCGGTGTTTAAC,40,upper,midpoint,70.47,40,0.6132,0,2.598
CellVaccineCohort,AUS24_s010_prevax,A/Sydney/591/2023,plate13-GGACATCTTTCAAGCA,40,upper,midpoint,45.15,40,0.6796,0,1.341
CellVaccineCohort,AUS24_s010_prevax,A/Sydney/591/2023,plate13-CTCTCTACAGTATTGA,40,upper,midpoint,40.14,40,0.7036,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Sydney/591/2023,plate13-ATTAGACAATAATGAC,41.66,interpolated,midpoint,54.01,41.66,0.6282,0,5.243
CellVaccineCohort,AUS24_s010_prevax,A/Ghana/1127/2023,plate13-GATAATAGAAAGTGTA,40,upper,midpoint,52.61,40,0.6821,0,2.229
CellVaccineCohort,AUS24_s010_prevax,A/Ghana/1127/2023,plate13-TCGACGCTTCATGGAA,40,upper,midpoint,71.68,40,0.649,0,1.921
CellVaccineCohort,AUS24_s010_prevax,A/Ghana/1127/2023,plate13-AAACATATTGGCGTTT,40,upper,midpoint,47.9,40,0.6991,0,1.516
CellVaccineCohort,AUS24_s010_prevax,A/Panama/M270337/2023,plate13-CAGAACACGATGGAAA,41.06,interpolated,midpoint,53.75,41.06,0.651,0,4.444
CellVaccineCohort,AUS24_s010_prevax,A/Panama/M270337/2023,plate13-GCAGTCTCCGGCTAGG,43.95,interpolated,midpoint,79.1,43.95,0.656,0,1.982
CellVaccineCohort,AUS24_s010_prevax,A/Panama/M270337/2023,plate13-GTCACTATATGATGTC,40,upper,midpoint,51.11,40,0.6968,0,3.321
CellVaccineCohort,AUS24_s010_prevax,A/Norway/8030/2023,plate13-GCGGTATTCATTAATA,44.7,interpolated,midpoint,84.99,44.7,0.6612,0,1.762
CellVaccineCohort,AUS24_s010_prevax,A/Norway/8030/2023,plate13-TTTGCTCGCAAAACCA,47.69,interpolated,midpoint,75.86,47.69,0.7018,0,1.955
CellVaccineCohort,AUS24_s010_prevax,A/Norway/8030/2023,plate13-GTTTCTGCCTTACAAA,40,upper,midpoint,61.3,40,0.6957,0,1.664
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1834/2023,plate13-CAAGGAAGTCAGGATT,40,upper,midpoint,40,40,0.8607,0,9.994
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1834/2023,plate13-CTCATATTCCTATGAC,40,upper,midpoint,40,40,0.7035,0,2.239
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1834/2023,plate13-GCATCCTTTTCCTGTT,40,upper,midpoint,44.98,40,0.6502,0,2.202
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1010/2023,plate13-GTAGAAATCATAGGCG,40,upper,midpoint,86.54,40,0.6,0,1.372
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1010/2023,plate13-AATTTTAGGACGCCGT,51.77,interpolated,midpoint,104.8,51.77,0.6241,0,1.976
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1010/2023,plate13-TCCCTTAGGCATAGCC,75.59,interpolated,midpoint,179.1,75.59,0.7023,0,1.049
CellVaccineCohort,AUS24_s010_prevax,A/Argentina/824/2023,plate13-TACTAAGTAAGAGCAA,40,upper,midpoint,40,40,0.6274,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Argentina/824/2023,plate13-ACAAATAGTTTATAGA,40,upper,midpoint,41.61,40,0.6949,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Argentina/824/2023,plate13-CCACATAGGCGTTTTT,60.71,interpolated,midpoint,77.62,60.71,0.7483,0,2.848
CellVaccineCohort,AUS24_s010_prevax,A/Wisconsin/588/2019,plate13-GAAGAAACTATAACCA,57.19,interpolated,midpoint,90.2,57.19,0.6761,0,2.29
CellVaccineCohort,AUS24_s010_prevax,A/Wisconsin/588/2019,plate13-TATATTAGTAACATAA,51.71,interpolated,midpoint,109.6,51.71,0.6,0,2.144
CellVaccineCohort,AUS24_s010_prevax,A/Wisconsin/588/2019,plate13-AGTCCTATCCTCAAAT,86.09,interpolated,midpoint,92.52,86.09,0.83,0,5.775
CellVaccineCohort,AUS24_s010_prevax,A/Norway/9845/2023,plate13-GTAAAGACCTTCGGAG,40,upper,midpoint,41.09,40,0.6252,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Norway/9845/2023,plate13-TGAAGCCATGAGTATC,40,upper,midpoint,40,40,0.7397,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Cambodia/KPH230176/2023,plate13-ATTTGAACAATGTCCA,40,upper,midpoint,40,40,0.7526,0,9.998
CellVaccineCohort,AUS24_s010_prevax,A/Cambodia/KPH230176/2023,plate13-CTGGAATGCAACGGGT,43.75,interpolated,midpoint,55.86,43.75,0.7109,0,3.532
CellVaccineCohort,AUS24_s010_prevax,A/Cambodia/KPH230176/2023,plate13-AACATGTGTAAGCGGT,40,upper,midpoint,52.6,40,0.693,0,1.188
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0053-796776/2023,plate13-TTCTATGTTTCTTTAA,40,upper,midpoint,69.2,40,0.6431,0,1.755
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0053-796776/2023,plate13-TCATAATAGGATGTTT,42.08,interpolated,midpoint,50.69,42.08,0.7091,0,4.681
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0053-796776/2023,plate13-CTCCGCGTGTACAGAT,61.45,interpolated,midpoint,74.28,61.45,0.803,0,2.642
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0048-796565/2023,plate13-TAACGGTATTCCCCAG,40,upper,midpoint,40,40,0.7046,0,1.866
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0048-796565/2023,plate13-CACGAGTTGGTGGGTT,40,upper,midpoint,42.86,40,0.6958,0,10
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0048-796565/2023,plate13-CAATCCGCTTGAATAC,40,upper,midpoint,51.22,40,0.7211,0,2.603
CellVaccineCohort,AUS24_s010_prevax,A/Senegal/1341/2023,plate13-CATGCAATTCAGAGGG,40,upper,midpoint,41.13,40,0.8075,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Senegal/1341/2023,plate13-AAGATGAATGTCTTAA,40,upper,midpoint,47.49,40,0.7554,0,2.776
CellVaccineCohort,AUS24_s010_prevax,A/Senegal/1341/2023,plate13-TAAAGACAAAAAAACC,40,upper,midpoint,46.39,40,0.7056,0,4.012
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0036-793184/2023,plate13-TAGGACTACAGAGAAC,40,upper,midpoint,40,40,0.6864,0,10
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0036-793184/2023,plate13-CGTTAAGTTGAAAAAA,40,upper,midpoint,51.6,40,0.6796,0,1.117
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0036-793184/2023,plate13-AATTGTGAATGCCACA,40,upper,midpoint,49.78,40,0.686,0,4.086
CellVaccineCohort,AUS24_s010_prevax,A/Arizona/43/2023,plate13-TGTGATAGACCTAGAA,40,upper,midpoint,40,40,0.7339,0,9.999
CellVaccineCohort,AUS24_s010_prevax,A/Arizona/43/2023,plate13-AGTCAGGAGTCATATA,40,upper,midpoint,71.96,40,0.6,0,2.242
CellVaccineCohort,AUS24_s010_prevax,A/Arizona/43/2023,plate13-TATGGCCTATAGGTTC,42.2,interpolated,midpoint,65.31,42.2,0.6533,0,2.707
CellVaccineCohort,AUS24_s010_prevax,A/Perth/372/2023,plate13-CTAGCAACATCTTCCT,40,upper,midpoint,42.42,40,0.6895,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Perth/372/2023,plate13-TTATAAAAACAAATCG,40,upper,midpoint,40,40,0.7213,0,1.752
CellVaccineCohort,AUS24_s010_prevax,A/Perth/372/2023,plate13-TCCTCTATTTTCTTCT,40,upper,midpoint,52.2,40,0.719,0,2.868
CellVaccineCohort,AUS24_s010_prevax,A/California/82/2023,plate13-TGGGAAATCATTGGTA,40,upper,midpoint,40,40,0.6457,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Senegal/1423/2023,plate13-ACGACCAAGTGGTAGT,40,upper,midpoint,81.32,40,0.6292,0,1.355
CellVaccineCohort,AUS24_s010_prevax,A/Senegal/1423/2023,plate13-ACTGCGTACAGAGGTA,43.01,interpolated,midpoint,47.79,43.01,0.6745,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Senegal/1423/2023,plate13-CACGAAATAGAACGTC,52.15,interpolated,midpoint,80.49,52.15,0.6982,0,2.132
CellVaccineCohort,AUS24_s010_prevax,A/PaisVasco/1994/2023,plate13-CGAAAGAACCTACCCG,65.51,interpolated,midpoint,149.8,65.51,0.6226,0,1.7
CellVaccineCohort,AUS24_s010_prevax,A/PaisVasco/1994/2023,plate13-TTATCACGTCTTTGCC,73.12,interpolated,midpoint,334.3,73.12,0.6,0,1.059
CellVaccineCohort,AUS24_s010_prevax,A/PaisVasco/1994/2023,plate13-CCAGCCACATAAAATT,72.27,interpolated,midpoint,156.2,72.27,0.677,0,1.347
CellVaccineCohort,AUS24_s010_prevax,A/Arizona/IVYG43Q65T3/2023,plate13-TAACAGTTAGACAAAA,40,upper,midpoint,48.25,40,0.6711,0,1.894
CellVaccineCohort,AUS24_s010_prevax,A/Arizona/IVYG43Q65T3/2023,plate13-TCACAATTCATATAAT,40,upper,midpoint,62.89,40,0.6802,0,2.201
CellVaccineCohort,AUS24_s010_prevax,A/Arizona/IVYG43Q65T3/2023,plate13-ATCTAATAATTATGGT,47.23,interpolated,midpoint,66.65,47.23,0.7679,0,1.812
CellVaccineCohort,AUS24_s010_prevax,A/Argentina/677/2023,plate13-ATATCAAGACTAGATG,40,upper,midpoint,57.28,40,0.6547,0,2.692
CellVaccineCohort,AUS24_s010_prevax,A/Argentina/677/2023,plate13-CGGCAGGATATTGCAG,44.54,interpolated,midpoint,65.33,44.54,0.706,0,2.315
CellVaccineCohort,AUS24_s010_prevax,A/Argentina/677/2023,plate13-CCGTTCTAAAACGCTA,40,upper,midpoint,42.64,40,0.7341,0,10
CellVaccineCohort,AUS24_s010_prevax,A/NakhonPhanom/P3460/2023,plate13-AAGGAAAATTCAAAGC,46.37,interpolated,midpoint,79.22,46.37,0.69,0,1.807
CellVaccineCohort,AUS24_s010_prevax,A/NakhonPhanom/P3460/2023,plate13-CTGTAAAAAGCGTTAA,40,upper,midpoint,66.59,40,0.7455,0,1.259
CellVaccineCohort,AUS24_s010_prevax,A/NakhonPhanom/P3460/2023,plate13-TCATTGTCAATATTGA,40,upper,midpoint,46.28,40,0.6,0,10
CellVaccineCohort,AUS24_s010_prevax,A/SouthAfrica/R06646/2023,plate13-ACTTAAAATCTTATAA,40,upper,midpoint,40,40,0.7199,0,1.617
CellVaccineCohort,AUS24_s010_prevax,A/SouthAfrica/R06646/2023,plate13-ACCTATTCTATTTTTC,51.36,interpolated,midpoint,65.78,51.36,0.7593,0,2.655
CellVaccineCohort,AUS24_s010_prevax,A/SouthAfrica/R06646/2023,plate13-TGTTTTACATTAGATG,43.61,interpolated,midpoint,60.28,43.61,0.7532,0,2.102
CellVaccineCohort,AUS24_s010_prevax,A/Valparaiso/41964/2023,plate13-TGCCATCTGTGCATTA,40,upper,midpoint,51.06,40,0.6,0,4.06
CellVaccineCohort,AUS24_s010_prevax,A/Valparaiso/41964/2023,plate13-AATGAATGTATGCTAA,51.26,interpolated,midpoint,95.64,51.26,0.6536,0,1.892
CellVaccineCohort,AUS24_s010_prevax,A/Valparaiso/41964/2023,plate13-CGCGAGCGTGAAATAA,50.62,interpolated,midpoint,66.55,50.62,0.7522,0,2.501
CellVaccineCohort,AUS24_s010_prevax,A/Washington/32/2023,plate13-TTGGGGATTGCCCAAA,40,upper,midpoint,44.93,40,0.6496,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Washington/32/2023,plate13-AAACTCATCAGACTGG,40,upper,midpoint,63.14,40,0.6186,0,2.171
CellVaccineCohort,AUS24_s010_prevax,A/Washington/32/2023,plate13-CGCCTGTAAAAATTCG,42.34,interpolated,midpoint,44.47,42.34,0.8061,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Para/2023-020942-IEC/2023,plate13-TGAGTACTGTATACCA,40,upper,midpoint,47.08,40,0.7078,0,3.666
CellVaccineCohort,AUS24_s010_prevax,A/Para/2023-020942-IEC/2023,plate13-TGCATTAATTCAACTA,50.87,interpolated,midpoint,66.58,50.87,0.7348,0,2.809
CellVaccineCohort,AUS24_s010_prevax,A/Para/2023-020942-IEC/2023,plate13-AGACGCTTCGGCCCAA,41.74,interpolated,midpoint,47.52,41.74,0.6367,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Sydney/130/2023,plate13-ACTACCGCTAATATGC,40,upper,midpoint,40,40,0.7264,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Sydney/130/2023,plate13-CAGATATGAGAGAGCA,40,upper,midpoint,40,40,0.8335,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Sydney/130/2023,plate13-CCATAACTGTATATGG,44.33,interpolated,midpoint,75.83,44.33,0.7459,0,1.322
CellVaccineCohort,AUS24_s010_prevax,A/Senegal/1382/2023,plate13-ATTATGGAAATAATGA,40,upper,midpoint,69.48,40,0.6551,0,1.955
CellVaccineCohort,AUS24_s010_prevax,A/Senegal/1382/2023,plate13-CAGGACGCAAAACACA,41.85,interpolated,midpoint,68.72,41.85,0.6,0,3.244
CellVaccineCohort,AUS24_s010_prevax,A/Senegal/1382/2023,plate13-CCCTATCCCAGAACCT,43.81,interpolated,midpoint,98.67,43.81,0.7009,0,1.123
CellVaccineCohort,AUS24_s010_prevax,A/Wisconsin/67/2022,plate13-AGGAAAGAAACTGGAG,40,upper,midpoint,40,40,0.6981,0,9.988
CellVaccineCohort,AUS24_s010_prevax,A/Wisconsin/67/2022,plate13-AAAGCTCTTTTCGTTC,40,upper,midpoint,40,40,0.711,0,9.999
CellVaccineCohort,AUS24_s010_prevax,A/Wisconsin/67/2022,plate13-CTGAACTTGTCGATAT,42.03,interpolated,midpoint,44.96,42.03,0.7545,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Sydney/166/2023,plate13-ATGGATATGCTATCAG,40,upper,midpoint,43.63,40,0.6119,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Sydney/166/2023,plate13-AGAACAATTATTGTTA,40,upper,midpoint,52.18,40,0.7114,0,1.974
CellVaccineCohort,AUS24_s010_prevax,A/Sydney/166/2023,plate13-AAGCCCAATAATAAGG,40,upper,midpoint,40,40,0.6953,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Jeonbuk/1544/2023,plate13-GTCATATTCGATTACA,40,upper,midpoint,40,40,0.785,0,9.992
CellVaccineCohort,AUS24_s010_prevax,A/Jeonbuk/1544/2023,plate13-TGGACACTTACAACAA,40,upper,midpoint,40,40,0.789,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Jeonbuk/1544/2023,plate13-AAAGCCCTAGTTAAGT,40,upper,midpoint,40,40,0.7215,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Norway/7787/2023,plate13-ATATGTGCTAACAAAA,40,upper,midpoint,61.86,40,0.637,0,0.8
CellVaccineCohort,AUS24_s010_prevax,A/Norway/7787/2023,plate13-CGCAGATATCATAGAA,40,upper,midpoint,46.97,40,0.7359,0,4.646
CellVaccineCohort,AUS24_s010_prevax,A/Norway/7787/2023,plate13-ATAAGAGAGCATCTCT,40,upper,midpoint,40,40,0.6172,0,9.999
CellVaccineCohort,AUS24_s010_prevax,A/Perth/275/2023,plate13-ATAGGCTAGAAAGGAA,40,upper,midpoint,40,40,0.6949,0,3.057
CellVaccineCohort,AUS24_s010_prevax,A/Perth/275/2023,plate13-CCTGTTTTTAGACGAA,40,upper,midpoint,43.82,40,0.6689,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Perth/275/2023,plate13-GTCCACAACAGTTGAA,40,upper,midpoint,40,40,0.6392,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Netherlands/1739/2023,plate13-ACTAAAGGCATAGTAG,40,upper,midpoint,40,40,0.6104,0,9.994
CellVaccineCohort,AUS24_s010_prevax,A/Netherlands/1739/2023,plate13-AATAAAATGCATGGGT,40,upper,midpoint,40,40,0.6564,0,1.584
CellVaccineCohort,AUS24_s010_prevax,A/Netherlands/1739/2023,plate13-TCTATCATCGCCGTTA,40,upper,midpoint,40,40,0.6843,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Chungbuk/1553/2023,plate13-AAATTAAAGAGGTTAA,40,upper,midpoint,40,40,0.697,0,9.999
CellVaccineCohort,AUS24_s010_prevax,A/Chungbuk/1553/2023,plate13-TTACCTCTGAGAAACG,40,upper,midpoint,54.51,40,0.6332,0,3.584
CellVaccineCohort,AUS24_s010_prevax,A/Chungbuk/1553/2023,plate13-AGCCCTTAAGACATTA,48.75,interpolated,midpoint,76.83,48.75,0.6645,0,2.444
CellVaccineCohort,AUS24_s010_prevax,A/Hawaii/70/2019,plate13-ATAGAATCGCAAATTA,59.12,interpolated,midpoint,98.9,59.12,0.7423,0,1.407
CellVaccineCohort,AUS24_s010_prevax,A/Hawaii/70/2019,plate13-TGGAATCGTCACCGAT,59.24,interpolated,midpoint,85.97,59.24,0.6951,0,2.527
CellVaccineCohort,AUS24_s010_prevax,A/Hawaii/70/2019,plate13-AGTAAACATGCATTGG,64.04,interpolated,midpoint,88.8,64.04,0.7291,0,2.388
CellVaccineCohort,AUS24_s010_prevax,A/Cambodia/SVH230198/2023,plate13-ATAGCATGCGATTTTA,40,upper,midpoint,40,40,0.7588,0,0.8718
CellVaccineCohort,AUS24_s010_prevax,A/Cambodia/SVH230198/2023,plate13-GTCTAACAAGAATGTA,42.03,interpolated,midpoint,55.48,42.03,0.6421,0,4.528
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1389/2023,plate13-TTTTAGATAAACTTAG,40,upper,midpoint,54.75,40,0.6364,0,2.219
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1389/2023,plate13-AAGATTACCAAATTAT,40,upper,midpoint,40,40,0.6505,0,1.689
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1389/2023,plate13-CGATGCACTCGTAAGT,40,upper,midpoint,66.39,40,0.6833,0,1.493
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0348-802602/2023,plate13-ACTTAGGAAGGTAAAC,40,upper,midpoint,43.42,40,0.6675,0,4.018
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0348-802602/2023,plate13-ACTTATGCTCTTGATA,41.04,interpolated,midpoint,65.81,41.04,0.6679,0,2.311
CellVaccineCohort,AUS24_s010_prevax,A/CostaRica/INC-0348-802602/2023,plate13-TAGTTGACTGTCGAGG,40,upper,midpoint,40.91,40,0.7314,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1013/2023,plate13-ATATTGTTAATATTCT,40,upper,midpoint,40,40,0.7283,0,1.686
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1013/2023,plate13-AAAATGCTGGGGTATA,40,upper,midpoint,40,40,0.7365,0,1.253
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1013/2023,plate13-CAGTCGCATTGAACCT,40,upper,midpoint,43.53,40,0.7936,0,1.004
CellVaccineCohort,AUS24_s010_prevax,A/Sydney/845/2023,plate13-GTATCCCCACGAAAGT,40,upper,midpoint,44.63,40,0.7005,0,1.985
CellVaccineCohort,AUS24_s010_prevax,A/Sydney/845/2023,plate13-ATTACCTAAGTGAAAT,40,upper,midpoint,45.27,40,0.6,0,10
CellVaccineCohort,AUS24_s010_prevax,A/California/75/2023,plate13-CTTCAAAGACTGATTA,40,upper,midpoint,40,40,0.7378,0,10
CellVaccineCohort,AUS24_s010_prevax,A/California/75/2023,plate13-TAACCGCTTCAATATA,40,upper,midpoint,40,40,0.6433,0,9.999
CellVaccineCohort,AUS24_s010_prevax,A/Brisbane/02/2018,plate13-TAATAAGCCAGCAAGA,45.23,interpolated,midpoint,55.26,45.23,0.7505,0,3.447
CellVaccineCohort,AUS24_s010_prevax,A/Brisbane/02/2018,plate13-TTGGGCACTAAATTAA,50.98,interpolated,midpoint,69.89,50.98,0.7384,0,2.347
CellVaccineCohort,AUS24_s010_prevax,A/Brisbane/02/2018,plate13-ATCCGATTTAAAGGCA,41.83,interpolated,midpoint,44.87,41.83,0.748,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Pennsylvania/46/2023,plate13-AGAAAGCTGTTAATAC,40,upper,midpoint,52.33,40,0.6599,0,3.919
CellVaccineCohort,AUS24_s010_prevax,A/Pennsylvania/46/2023,plate13-GAAAATGATCCACATT,40.67,interpolated,midpoint,43.09,40.67,0.7804,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Pennsylvania/46/2023,plate13-AAATAATGAGTTTATA,40,upper,midpoint,56.22,40,0.6589,0,2.7
CellVaccineCohort,AUS24_s010_prevax,A/Tasmania/140/2023,plate13-TATGACATTAGAAACA,40,upper,midpoint,40,40,0.6661,0,9.992
CellVaccineCohort,AUS24_s010_prevax,A/Tasmania/140/2023,plate13-CAACGGATTCTTGTTG,40,upper,midpoint,83.73,40,0.6088,0,1.868
CellVaccineCohort,AUS24_s010_prevax,A/Tasmania/140/2023,plate13-GAGAGTACGGCACTGA,40.04,interpolated,midpoint,52.45,40.04,0.6213,0,5.247
CellVaccineCohort,AUS24_s010_prevax,A/Denmark/1567/2023,plate13-TAGTAATCTAAAGTAA,40,upper,midpoint,42.58,40,0.6669,0,6.211
CellVaccineCohort,AUS24_s010_prevax,A/Denmark/1567/2023,plate13-ACCCCTTCAGAAGTTA,44.81,interpolated,midpoint,64.73,44.81,0.6783,0,2.804
CellVaccineCohort,AUS24_s010_prevax,A/Denmark/1567/2023,plate13-TCCGAAAGACCAAAAC,47.49,interpolated,midpoint,50.82,47.49,0.7537,0,10
CellVaccineCohort,AUS24_s010_prevax,A/EspiritoSanto/6964/2023,plate13-AAATAAGTATCCTAAA,40.27,interpolated,midpoint,54.84,40.27,0.6329,0,4.291
CellVaccineCohort,AUS24_s010_prevax,A/EspiritoSanto/6964/2023,plate13-AGCATCACGTCAGTCT,40,upper,midpoint,40,40,0.683,0,1.362
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/2241/2023,plate13-TATTCAACATTCTCTA,40,upper,midpoint,41.7,40,0.7345,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/2241/2023,plate13-TGAATGATTCTCCTTT,40,upper,midpoint,56.79,40,0.7292,0,2.161
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/2241/2023,plate13-GTAATACTGATGGGCA,40,upper,midpoint,66.17,40,0.6569,0,1.935
CellVaccineCohort,AUS24_s010_prevax,A/Singapore/GP7085/2023,plate13-CCCCAACCTATCGTAA,84.89,interpolated,midpoint,370.4,84.89,0.6327,0,0.9002
CellVaccineCohort,AUS24_s010_prevax,A/Singapore/GP7085/2023,plate13-AAAGTGAGACCTGTAC,72.41,interpolated,midpoint,203.7,72.41,0.6102,0,1.463
CellVaccineCohort,AUS24_s010_prevax,A/Gwangju/1254/2023,plate13-GACAATATACCCCCAT,40,upper,midpoint,54.27,40,0.6,0,1.447
CellVaccineCohort,AUS24_s010_prevax,A/Gwangju/1254/2023,plate13-GGCTTGAATGATATTG,40,upper,midpoint,45.2,40,0.6325,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Gwangju/1254/2023,plate13-GTCAAATAAATTTTCA,40,upper,midpoint,60.28,40,0.6075,0,1.979
CellVaccineCohort,AUS24_s010_prevax,A/RioGrandedoSul/6798/2023,plate13-ACGGCAAGTGATGAAA,40,upper,midpoint,91.81,40,0.6771,0,1.236
CellVaccineCohort,AUS24_s010_prevax,A/RioGrandedoSul/6798/2023,plate13-CCAAATTTTAACTGTG,40.39,interpolated,midpoint,45.2,40.39,0.6622,0,10
CellVaccineCohort,AUS24_s010_prevax,A/RioGrandedoSul/6798/2023,plate13-AATCCATTAGTTCAGC,40,upper,midpoint,40,40,0.6486,0,1.905
CellVaccineCohort,AUS24_s010_prevax,A/ChiangRai/P3437/2023,plate13-GGATTACACGATACCG,65.04,interpolated,midpoint,76.75,65.04,0.7597,0,3.956
CellVaccineCohort,AUS24_s010_prevax,A/ChiangRai/P3437/2023,plate13-AAACTGATTAATGATG,50.99,interpolated,midpoint,97.43,50.99,0.6122,0,2.308
CellVaccineCohort,AUS24_s010_prevax,A/ChiangRai/P3437/2023,plate13-AATGATAACTTAAAAA,55.81,interpolated,midpoint,88.22,55.81,0.6903,0,2.109
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1384/2023,plate13-CTCCTAATAAAAAACT,40,upper,midpoint,53.75,40,0.6243,0,1.06
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1384/2023,plate13-CGCATGCAATTATAAA,41,interpolated,midpoint,45.11,41,0.6922,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/1384/2023,plate13-CAAAAACTTTAATTTC,41.23,interpolated,midpoint,49.42,41.23,0.7914,0,2.981
CellVaccineCohort,AUS24_s010_prevax,A/Michigan/45/2015,plate13-TTGAAAAAATCATAAA,70.9,interpolated,midpoint,114.8,70.9,0.702,0,1.88
CellVaccineCohort,AUS24_s010_prevax,A/Michigan/45/2015,plate13-ACAAAGTCTCGAGAAG,104,interpolated,midpoint,183.1,104,0.6364,0,2.298
CellVaccineCohort,AUS24_s010_prevax,A/Michigan/45/2015,plate13-CACCTAGGATCGCACT,84.73,interpolated,midpoint,100.1,84.73,0.7369,0,4.468
CellVaccineCohort,AUS24_s010_prevax,A/Perth/110/2023,plate13-ACGTAAAAAGGATATC,40,upper,midpoint,40,40,0.7159,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Perth/110/2023,plate13-GCAGAACATAAAACTC,40.01,interpolated,midpoint,43.99,40.01,0.6937,0,10
CellVaccineCohort,AUS24_s010_prevax,A/NewHampshire/7/2023,plate13-TGAACTAGACTTTCAA,52.33,interpolated,midpoint,82.91,52.33,0.6922,0,2.077
CellVaccineCohort,AUS24_s010_prevax,A/NewHampshire/7/2023,plate13-AAGTAGTGATTAAGCA,54.16,interpolated,midpoint,104.2,54.16,0.6443,0,1.9
CellVaccineCohort,AUS24_s010_prevax,A/NewHampshire/7/2023,plate13-CTGCACTCCGTAAATT,58.28,interpolated,midpoint,85.1,58.28,0.7632,0,1.695
CellVaccineCohort,AUS24_s010_prevax,A/SouthAustralia/179/2023,plate13-ATAGGCATGCTTACTG,40,upper,midpoint,41.86,40,0.7431,0,10
CellVaccineCohort,AUS24_s010_prevax,A/SouthAustralia/179/2023,plate13-TAAATGGTACAGAGGT,40,upper,midpoint,43.3,40,0.6933,0,10
CellVaccineCohort,AUS24_s010_prevax,A/Michigan/MISAPPHIREL365374393/2023,plate13-TTCTATAGTACTTCTA,43.12,interpolated,midpoint,66.2,43.12,0.6436,0,2.909
CellVaccineCohort,AUS24_s010_prevax,A/Michigan/MISAPPHIREL365374393/2023,plate13-ATCCCATCAACAAAAT,40,upper,midpoint,59.43,40,0.7044,0,2.168
CellVaccineCohort,AUS24_s010_prevax,A/Michigan/MISAPPHIREL365374393/2023,plate13-GGATTGTAATAAATCA,40,upper,midpoint,48.64,40,0.6906,0,4.483
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/4897/2022_IVR238,plate13-AAGTTAAGAGAAAGTT,98.74,interpolated,midpoint,111.2,98.74,0.8427,0,3.175
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/4897/2022_IVR238,plate13-AGAGCTAAAAAGAGGA,116.6,interpolated,midpoint,137.2,116.6,0.7907,0,3.333
CellVaccineCohort,AUS24_s010_prevax,A/Victoria/4897/2022_IVR238,plate13-AATCCGAAATTTATTC,119.7,interpolated,midpoint,124.9,119.7,0.8683,0,7.103
CellVaccineCohort,AUS24_s010_prevax,A/Oregon/Flu-OHSU-241140095/2023,plate13-CAAGGAAACCGGTTGA,105.2,interpolated,midpoint,171.5,105.2,0.7336,0,1.558
CellVaccineCohort,AUS24_s010_prevax,A/Oregon/Flu-OHSU-241140095/2023,plate13-AGCAGTAAATAAAATC,158.4,interpolated,midpoint,297.3,158.4,0.6463,0,1.952
CellVaccineCohort,AUS24_s010_prevax,A/California/07/2009,plate13-GACACAGAACCCATGC,152.8,interpolated,midpoint,266.6,152.8,0.6,0,2.893
CellVaccineCohort,AUS24_s010_prevax,A/California/07/2009,plate13-CCTTTCTCAAAACATA,92.34,interpolated,midpoint,139.2,92.34,0.6704,0,2.621
CellVaccineCohort,AUS24_s010_prevax,A/California/07/2009,plate13-CATGTGAATTCGCCCA,157.3,interpolated,midpoint,301,157.3,0.602,0,2.45
